Robo1 CAR-NK92 and radiotherapy exert synergistic efficacy in solid tumors
Abstract Background The efficacy of chimeric antigen receptor natural killer (CAR-NK) cells in treating solid tumors is often limited, primarily due to the tumor microenvironment (TME), which hinders the recognition and infiltration of CAR-NK cells. Radiotherapy has been shown to modify the TME, enh...
Saved in:
| Main Authors: | Mengdi Wu, Jie He, Jiaxiao Geng, Zhiming Wei, Rong Cheng, Huashun Li, Ligang Xing |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06753-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The clinical landscape of CAR NK cells
by: Lasse Vedel Jørgensen, et al.
Published: (2025-03-01) -
Leukoreduction filter derived NK cells offer a promising source for off the shelf CAR NK cell immunotherapy
by: Ali Moazzeni, et al.
Published: (2025-04-01) -
GD2-CAR NK-92 cell activity against neuroblastoma cells is insusceptible to TIGIT knockout
by: Wiebke Jünemann, et al.
Published: (2025-05-01) -
CAR‐NK, a Splendid Strategy for Cancer, Especially for Gynecologic Tumor
by: Yisen Cao, et al.
Published: (2025-06-01) -
Natural killer cell-based cancer immunotherapy: from basics to clinical trials
by: Yinghong Shi, et al.
Published: (2024-10-01)